Anne Holm

Director, Group Treasurer

Nycomed, Switzerland

Industry:
Pharmaceutical
Annual turnover:
€3.2bn
Treasury staff:
6
Treasury structure:
Centralised (A few regionalised)
TMS:
Yes
Cross-border pooling:
Yes
Cash rich or debt:
Debt leverage 3.6

Speaker profile

Anne has been working in Group Treasury within Nycomed since 2003 and has been Group Treasurer since 2007. Before joining Nycomed, she was with DSB (Danish railway company), responsible for the raising debt. Prior to this, she spent 9 years in a company within the Viola Group, with responsibility for the Treasury department. She originally has a background in the financial sector with a focus on Structured Finance and Project Financing.

Corporate profile

Nycomed is a privately owned, global pharmaceutical company with headquarters in Zurich, Switzerland. The company employs 12,000 associates worldwide and has affiliates in over 50 countries. Nycomed has a strong presence in Europe and in the emerging markets in Russia/Commonwealth of Independent States, Asia and Latin America. Nycomed’s differentiated portfolio of branded medicines is focused on gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. In 2009, total sales reached € 3.2 billion. Nycomed ranks 28th among global pharmaceutical companies and is the 16th largest provider of OTC medicines.